| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.54M | 4.14M | 6.11M | 8.42M | 8.64M | 6.70M |
| Gross Profit | 2.08M | 2.12M | 3.45M | 4.39M | 4.12M | 3.28M |
| EBITDA | 538.00K | 69.00K | 1.37M | 1.96M | 2.58M | 1.55M |
| Net Income | -972.00K | 902.00K | 1.84M | 3.21M | 2.01M | 1.36M |
Balance Sheet | ||||||
| Total Assets | 17.09M | 17.64M | 18.01M | 17.14M | 17.12M | 14.26M |
| Cash, Cash Equivalents and Short-Term Investments | 3.96M | 9.39M | 9.84M | 7.25M | 7.54M | 6.65M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 163.00K |
| Total Liabilities | 2.02M | 1.07M | 1.16M | 1.00M | 2.74M | 1.02M |
| Stockholders Equity | 15.06M | 16.56M | 16.84M | 16.14M | 14.38M | 13.24M |
Cash Flow | ||||||
| Free Cash Flow | 696.00K | -490.00K | 2.94M | 1.69M | 1.72M | 2.04M |
| Operating Cash Flow | 714.00K | -258.00K | 3.15M | 1.69M | 1.74M | 2.05M |
| Investing Cash Flow | -333.00K | -547.00K | -1.01M | -968.00K | -1.52M | -17.00K |
| Financing Cash Flow | -1.11M | -1.20M | -1.15M | -1.50M | -889.00K | -592.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $1.48B | 18.16 | 9.30% | 1.02% | 3.19% | -4.91% | |
71 Outperform | $5.07B | 25.55 | 4.71% | 2.77% | -2.30% | -29.75% | |
64 Neutral | $6.82B | 14.75 | 7.70% | ― | 3.16% | 1.09% | |
64 Neutral | $943.31M | 13.77 | 8.11% | ― | -4.88% | 2.57% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | $16.22M | 10.04 | 7.76% | ― | 5.12% | ― | |
56 Neutral | $10.66M | -10.84 | -4.12% | 14.21% | ― | ― |
On November 10, 2025, Taitron Components‘ Board of Directors decided to voluntarily delist its common stock from The Nasdaq Stock Market and deregister under the Securities Exchange Act of 1934 due to the high costs and demands of maintaining its public status outweighing the benefits. The delisting is expected to be effective on December 4, 2025, with potential trading on the OTC Markets Group, though no assurance is provided. Additionally, on the same date, David Vanderhorst resigned as CFO and Secretary, transitioning to the role of Controller, while CEO Stewart Wang took over his financial duties.